Lab Thread Ltd, a UK-based life science software company, today announced the beta launch of its flagship unified lab ...
TwistedSifter on MSN
Emotional doctors reveal new treatment for once incurable brain condition has a 75% success rate
UCLH Affecting around 41,000 people in the US, and with 200,000 more genetically predisposed to developing it, Huntington’s ...
Maternal obesity changes the gut bacteria of infants, potentially affecting their metabolism and health later in life, finds new research from Nazarbayev University (NU). The researchers, Almagul ...
Study Finds on MSN
Childhood Virus Linked To Bladder Cancer Decades Later
A virus carried by 95% of adults from childhood may trigger bladder cancer decades later by damaging cells during immune ...
The City of Sydney has engaged leading creative studio VANDAL to deliver the creative direction and innovative large-scale projections for Sydney New Year’s Eve 2025, transforming the Sydney Harbour ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Over the last decade, the number of cell and gene therapy clinical trials has more than tripled. In this article, several ...
This article is all about what’s new and what it might mean for us, covering the latest in genetics in news. New methods like ...
RRS Sir David Attenborough scientists are trying to measure the potentially crucial role of ocean manganese, finds. But how ...
Morning Overview on MSN
Tiny quakes spark a microbial awakening under Yellowstone
Far beneath Yellowstone’s steaming pools and geysers, a swarm of tiny earthquakes has jolted a hidden ecosystem into overdrive. Instead of simply cracking rock, the shaking appears to have stirred up ...
Data presented at ASH suggested that CDK4/6 inhibitors given with chemo for Rb-deficient tumors could mitigate the risk of secondary myeloid neoplasms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results